medrxiv
preprint
background
outbreak
caus
novel
coronaviru
term
spread
countri
around
world
current
revers
transcript
quantit
qpcr
rtqpcr
use
gold
standard
diagnost
howev
posit
rate
rtqpcr
assay
pharyng
swab
sampl
report
vari
accur
sensit
method
urgent
need
support
qualiti
assur
rtqpcr
altern
diagnost
approach
establish
revers
transcript
digit
pcr
rtdpcr
protocol
detect
clinic
pharyng
swab
sampl
includ
suspect
patient
close
contact
suppos
convalesc
limit
blank
lob
rtdpcr
assay
copiesreact
orf
n
e
gene
respect
limit
detect
lod
copiesreact
fever
suspect
patient
sensit
detect
significantli
improv
rtqpcr
rtdpcr
close
contact
suspect
rate
greatli
decreas
overal
sensit
specif
diagnost
accuraci
rtdpcr
respect
addit
quantif
viral
load
convalesc
rtdpcr
show
longer
observ
period
need
hospit
elderli
patient
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
howev
rtqpcr
report
issu
low
posit
rate
throat
swab
sampl
patient
neg
rtqpcr
test
result
initi
present
chest
ct
check
indic
typic
symptom
viral
pneumonia
order
identifi
hospit
patient
time
sensit
accur
test
requir
digit
pcr
dpcr
technolog
partit
nucleic
acid
molecul
across
larg
number
smaller
reaction
acquir
amplif
data
partit
end
point
base
intens
fluoresc
quantif
perform
appli
poisson
statist
proport
neg
partit
account
posit
partit
initi
contain
one
target
molecul
dpcr
offer
greater
precis
qpcr
far
simpler
use
copi
number
quantif
due
binari
natur
partit
count
posit
neg
addit
dpcr
toler
pcr
inhibit
compar
qpcr
due
partit
endpoint
pcr
measur
consequ
less
depend
high
pcr
effici
provid
bjcdc
extract
rna
store
primer
probe
sequenc
detect
n
gene
target
publish
chines
cdc
use
studi
sec
cycl
plate
transfer
droplet
reader
biorad
analyz
use
quantasoft
droplet
reader
softwar
biorad
reaction
contain
droplet
treat
effect
involv
data
analysi
establish
limit
blank
lob
blank
measur
obtain
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
blank
sampl
three
day
measur
sampl
low
concentr
cpreaction
use
determin
limit
detect
lod
accord
clsi
guidelin
three
differ
commerci
rtqpcr
kit
h
r
shanghai
huirui
biotechnolog
co
ltd
biogerm
shanghai
biogerm
medic
biotechnolog
daan
daan
gene
co
ltd
use
detect
briefli
reaction
contain
l
pcr
reaction
buffer
primer
probe
mixtur
l
rna
prepar
thermal
cycl
perform
min
revers
transcript
follow
min
cycl
abi
rtpcr
thermocycl
data
analysi
perform
use
softwar
abi
rtpcr
thermocycl
linear
rang
investig
vari
mean
copi
number
per
droplet
denot
precis
rel
error
rtdpcr
relat
gene
assay
determin
lower
limit
three
assay
serial
dilut
rna
transcript
prepar
supplement
tabl
measur
target
match
anticip
valu
test
interv
good
linear
slope
r
measur
rna
target
prepar
valu
observ
rang
approxim
copiesreact
fig
reaction
contain
mean
e
n
copi
fulfil
criterion
loq
cv
lower
sixti
blank
measur
obtain
blank
sampl
analyz
determin
lob
distribut
blank
measur
skew
supplement
tabl
percentil
correspond
order
observ
linear
interpol
observ
yield
lob
estim
copiesreact
e
n
respect
determin
lod
gene
assay
measur
perform
five
sampl
differ
run
three
differ
day
ensur
total
assay
variat
reflect
distribut
measur
result
low
concentr
sampl
gaussian
supplement
fig
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
nonparametr
statist
use
accord
guidelin
consequ
lod
determin
copiesreact
lowest
level
materi
percentil
determin
lod
n
e
assay
measur
e
assay
sampl
measur
n
assay
sampl
perform
differ
run
similar
gene
distribut
measur
n
gene
measur
gaussian
supplement
fig
nonparametr
statist
use
consequ
lod
determin
copi
reaction
specif
assay
e
gene
test
previou
report
valid
specif
assay
influenza
viru
human
coronaviru
collect
assay
test
human
clinic
nucleic
acid
sampl
nation
institut
metrolog
china
test
return
neg
result
see
supplement
tabl
pharyng
swab
collect
febril
suspect
infect
patient
relev
inform
list
tabl
among
specimen
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
test
kxr
h
r
qpcr
kit
test
whcdc
daan
qpcr
kit
firstli
criteria
claim
h
r
kit
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
determin
posit
base
parallel
test
commerci
kit
chines
cdc
assay
therefor
sampl
report
posit
bjcdc
qpcr
neg
posit
test
rtdpcr
show
high
sensit
rtdpcr
neg
complement
e
gene
target
among
specimen
posit
neg
suspect
report
rtqpcr
howev
sampl
includ
neg
suspect
test
qpcr
confirm
posit
rtdpcr
thu
patient
total
whose
nucleic
acid
posit
test
diagnos
patient
confirm
infect
accord
followup
survey
sensit
detect
significantli
improv
patient
fig
specimen
collect
contact
close
contact
specimen
contact
report
neg
base
rtqpcr
test
bjcdc
feb
confirm
rtdpcr
feb
supplement
tabl
accord
followup
survey
good
health
isol
lift
day
detect
nucleic
acid
due
low
viral
load
earli
stage
close
contact
howev
equivoc
one
neg
determin
posit
rtdpcr
suspect
rate
significantli
decreas
accord
detect
rtdpcr
consequ
except
patient
track
rest
rtdpcr
posit
confirm
infect
patient
base
followup
survey
furthermor
among
specimen
correct
rtdpcr
person
supplement
tabl
direct
secondari
test
follow
initi
neg
test
day
prior
base
rtqpcr
result
isol
observ
still
need
conduct
test
result
suspect
neg
clinic
symptom
observ
howev
base
rtdpcr
six
patient
diagnos
infect
treatment
could
conduct
earlier
indic
rtdpcr
sensit
suitabl
low
viral
load
specimen
patient
isol
observ
without
clinic
symptom
agreement
recent
onlin
report
addit
pharyng
swab
collect
convalesc
patient
tabl
posit
suspect
neg
report
qpcr
howev
patient
diagnos
posit
rtdpcr
indic
still
need
observ
hospit
regardless
sampl
time
correl
age
rna
viru
copi
number
analyz
interestingli
confirmatori
method
particular
import
diagnosi
outbreak
current
besid
rtqpcr
method
next
gener
sequenc
overal
sensit
diagnost
accuraci
rtqpcr
studi
respect
accord
followup
survey
sampl
track
rtqpcr
sensit
agreement
previou
report
throat
swab
sampl
howev
sensit
diagnost
accuraci
rtdpcr
dramat
increas
respect
furthermor
sensit
low
viral
load
close
contact
suitabl
monitor
chang
viral
load
convalesc
patient
addit
advantag
quantif
copi
number
rtdpcr
comparison
conduct
differ
date
differ
laboratori
absolut
quantit
target
rtdpcr
provid
high
concord
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
site
run
oper
howev
possibl
compar
ct
valu
differ
run
differ
machin
thu
rtdpcr
ideal
method
measur
chang
viru
load
convalesc
patient
work
demonstr
rtdpcr
significantli
improv
accuraci
reduc
fals
neg
rate
diagnost
could
power
complement
current
rtqpcr
furthermor
rtdpcr
sensit
suitabl
low
viru
load
specimen
patient
isol
observ
may
exhibit
clinic
symptom
supplement
materi
avail
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
n
e
respect
n
e
gene
copi
number
higher
threshold
patient
elder
patient
elder
median
